Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06637436 · ClinicalTrials.gov registry record · NA

PrEP Readiness Interventions for Sustained Motivation (PRISM)

A NA study of HIV and Methamphetamine Disorders, sponsored by Florida International University.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
2
Study locations

NCT06637436: Recruiting NA study of HIV and Methamphetamine Disorders, sponsored by Florida International University.

NCT06637436 is a NA study of HIV and Methamphetamine Disorders that is actively recruiting participants, run by Florida International University. The registered enrollment target is 400 participants, roughly in line with the 439-participant average among 303 other HIV trials with a reported enrollment target. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06637436, a NA study of HIV and Methamphetamine Disorders, is actively recruiting participants, sponsored by Florida International University.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
2
Study locations

Study Summary

This is a hybrid type I, factorial randomized controlled trial to test the comparative and combined effectiveness of contingency management (CM) alone or CM with motivational interviewing (MI) for optimizing entry or re-entry into the PrEP care continuum. A total of 400 participants will be randomized to CM (n = 200) or MI+CM (n = 200), all delivered via Telehealth. Monthly follow-up assessments will be completed over 12 months to examine differential effectiveness for the primary outcome - filling a PrEP prescription (verified using a digital photo or detectable tenofovir diphosphate). Secondary outcomes will include: self-reported PrEP clinical evaluation by a PrEP provider; self-reported meth and other substance use severity (ASSIST), and self-reported receptive and insertive condomless anal sex (CAS).

Primary Outcome

The proportion of participants providing evidence of PrEP or ART use (i.e., a digital photo a medication bottle bearing their name OR evidence of receipt of medication from a medical record)

Interventions

  • BEHAVIORAL Contingency Management (CM)
  • BEHAVIORAL Motivational Interviewing (MI)

Study Locations (2)

Florida

  • Florida International University Stempel College of Public Health and Social Work - Miami
  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2025-01-28
Est. Completion 2028-04-30
Phase NA
Florida International University

89 total trials

What NCT06637436 shows while recruiting

NCT06637436 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 439-participant average among 303 other HIV trials with a reported enrollment target.

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management (CM) is the first listed.

NCT06637436 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06637436 about?

NCT06637436 is a clinical study titled "PrEP Readiness Interventions for Sustained Motivation (PRISM)". This is a hybrid type I, factorial randomized controlled trial to test the comparative and combined effectiveness of contingency management (CM) alone or CM with motivational interviewing (MI) for optimizing entry or re-entry into the PrEP care continuum. A total of 400 participants will be randomiz...

What is the current status of trial NCT06637436?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-01-28. Estimated completion is 2028-04-30.

What conditions does trial NCT06637436 study?

This clinical trial studies the following conditions: HIV, Methamphetamine Disorders.

What interventions are being tested in trial NCT06637436?

The interventions under investigation include: Contingency Management (CM) (BEHAVIORAL), Motivational Interviewing (MI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06637436?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06637436 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06637436's enrollment target sits among peer trials

400 39th of 303 higher than 257 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06637436, the US trial registry maintained by the National Library of Medicine. NCT06637436 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.